Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ineke M. Olsthoorn"'
Autor:
Peter L. Stavinoha, Ineke M. Olsthoorn, Maria C. Swartz, Sara Nowakowski, Stephanie J. Wells, Rachel S. Hicklen, Irtiza Sheikh, Hannah J. Jang
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-7 (2021)
Abstract Background Sleep disturbances constitute a common complication in pediatric cancer patients and survivors and are frequently severe enough to warrant treatment. Suboptimal sleep has been associated with decreased emotional well-being and cog
Externí odkaz:
https://doaj.org/article/acd2a2ffd9ec48979b6f289ec7390c55
Autor:
Ineke M. Olsthoorn, Alice Ann Holland, Raymond C. Hawkins, Allen E. Cornelius, Muhammad Usman Baig, Grace Yang, Daniel C. Holland, Wafik Zaky, Peter L. Stavinoha
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
BackgroundPediatric brain tumor (PBT) survivors are at risk for developing sleep disturbances. While in other pediatric populations sleep disturbance has been associated with worse cognitive functioning, it is unclear to what extent this relationship
Externí odkaz:
https://doaj.org/article/e537426f480c458eb41ffdd33be3ad2e
Autor:
Rachel S Hicklen, Hannah J Jang, Irtiza N. Sheikh, Stephanie J. Wells, Ineke M Olsthoorn, Peter L. Stavinoha, Maria C. Swartz, Sara Nowakowski
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-7 (2021)
Systematic Reviews
Systematic Reviews
Background Sleep disturbances constitute a common complication in pediatric cancer patients and survivors and are frequently severe enough to warrant treatment. Suboptimal sleep has been associated with decreased emotional well-being and cognitive fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec256ba88d4b82332c740eba0804f75
https://doaj.org/article/acd2a2ffd9ec48979b6f289ec7390c55
https://doaj.org/article/acd2a2ffd9ec48979b6f289ec7390c55
Publikováno v:
Neuro-Oncology
BACKGROUND Predicting neurocognitive outcomes in pediatric brain tumor (PBT) patients is challenging. Rarity of PBT makes inclusion of detailed risk factors (e.g., treatment modality, intensity, individual complications) difficult when sample sizes a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851b0e0eb6bc54b7d2a1192de6a610e7
http://europepmc.org/articles/PMC7715963
http://europepmc.org/articles/PMC7715963